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Determining transition readiness in Swiss
childhood cancer survivors – a feasibility
study
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Abstract
Background: The successful transition of childhood cancer survivors (CCSs) from pediatric to adult long-term
follow-up care is a critical phase, and determining the right time point can be challenging. We assessed the
feasibility of the use of existing transition readiness tools in the context of the Swiss health care system, assessed
partly transition readiness in Swiss CCSs, and compared our findings with Canadian CCSs for which these tools
were originally developed.
Methods: We officially translated the Cancer Worry Scale (CWS) and Self-Management Skill Scale (SMSS) into
German and integrated them into this cross-sectional study. We included CCSs attending the long-term follow-up
(LTFU) clinic in the Division of Oncology-Hematology, Department of Pediatrics, Kantonsspital Aarau. We used
descriptive statistics to describe transition readiness.
Results: We randomly recruited 50 CCSs aged ≥18 years at participation. The CCSs had a median CWS score of 62
(interquartile range 55–71), indicating a moderate level of cancer-related worry. Despite high self-management
skills, some answers showed a dependency of CCSs on their parents. Our experience shows that the CWS and SMSS
are easy for Swiss CCSs to use, understand, and complete. The interpretation of the results must take differences in
health care systems between countries into account.
Conclusions: The translated CWS and SMSS are appropriate additional measures to assess transition readiness in
CCSs. These scales can be used longitudinally to find the individual time point for transition and the completion by
CCSs enables the health care team to individualize the transition process and to support the CCSs according to
their individual needs.
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Background
Transition is a critical period in the long-term follow-up
(LTFU) care of childhood cancer survivors (CCSs).
Transition generally describes the “purposeful, planned
movement of adolescents and young adults with chronic
physical and medical conditions from child-centered to
adult-oriented health-care systems” [1]. This change in
care is very important for CCSs, as the survival rate has
increased substantially in recent decades [2], but survival
is often associated with the risk of developing chronic
medical and psychosocial late effects [3, 4]. Depending
on the treatment received, these late effects can poten-
tially affect any organ system [3, 5, 6]. The frequency of
late effects increases with the time elapsed since the
cancer diagnosis, and many late effects do not manifest
until adulthood [3]. This carries the risk of adolescent
and young adult CCSs no longer feeling the need for
LTFU care [7, 8]. To prevent loss to follow-up and
ensure the continuation of follow-up in adulthood, a
well-organized and prepared transition process from
pediatric- to adult-focused LTFU care is required. This
transition can be part of and result in different LTFU
care models for adult CCSs: a) models with transition to
primary care physicians only, b) shared-care models with
LTFU care provided by the primary care physician in
collaboration with pediatric or adult oncologists, c)
models with direct transition from pediatric to adult
oncologists or d) models with transition to LTFU clinics,
which provide LTFU care in multidisciplinary teams [9–11].
All these models have two aspects in common: they depend
on physicians committed to LTFU care, and it can be
challenging to find the right time to initiate the transition
process and to perform the actual transfer. A proper assess-
ment of CCSs’ individual transition readiness is needed.
Survivor-related factors can influence transition readiness,
such as CCSs’ personal responsibility concerning their health
or knowledge of possible late effects and the reasons LTFU
care is important [12]. To address these aspects, Klassen
et al. developed and validated scales to measure CCSs’ transi-
tion readiness – the Cancer Worry scale (CWS) and the
Self-Management Skills (SMSS) scale [13].
After officially translating both scales into German, we
primarily aimed to assess the feasibility of using these
scales in clinical practice and in the context of a differ-
ent health care system than the one in which they were
initially developed. Within this context, we aimed to
assess the added value to transition readiness in Swiss
CCSs aged ≥18 years.
Methods
Participants
Childhood cancer survivors ≥18 years old at participation;
with ≥5 years since cancer diagnosis; who were enrolled in
LTFU care at the Division of Oncology-Hematology,
Department of Pediatrics, Kantonsspital Aarau; who
planned to transition to adult care; and who had been
younger than 18 years old at the time of their cancer diag-
nosis were eligible. We excluded CCSs who were not able
to fill out the survey on their own due to language barriers
or lacking the cognitive capacity.
Assessment measures
The questionnaire used for this cross-sectional study
consisted of two parts (Supplemental 1). The first part
asked three demographic questions about cancer type,
age at diagnosis, and treatment received. The second
part corresponded to the translated CWS and the SMSS,
originally developed by Klassen et al. [13]. The 6-item
CWS focuses on the CCSs’ worries related to the cancer
itself and to possible late effects. The 15-item SMSS
assesses whether CCSs have enough skills to manage
their own health. There are four possible answers to all
questions, ranging from “strongly agree” to “strongly
disagree”. The answers to the CWS can be transformed
into a score ranging from 0 to 100, where higher scores
show fewer cancer-related worries. No scoring system
exists for the SMSS.
We obtained permission from McMaster University in
Hamilton, Canada, to use the scales and translated them
following a common translation procedure regulated by
the Q-portfolio team (www.qportfolio.org). In the first
step, two forward translators whose native language was
German and who were fluent in English translated the
scales from English to German independently of each
other. The project manager (KS) combined these trans-
lations into a single version. A back translator whose
native language was English and who was blinded to the
original English version and was fluent in German then
translated the combined version back into English. Five
CCSs with different ages, diagnoses, sexes, and treat-
ments tested the German version for understandability.
Ethics approval to perform this study was obtained
from the Ethikkommission Nordwest und Zentralschweiz
(EKNZ).
Recruitment
In January 2018, a combined transition clinic was estab-
lished at Kantonsspital Aarau. This clinic is part of the
LTFU care and is staffed by pediatric oncologists and
adult oncologists and hematologists. If required, add-
itional specialists in adult medicine participate in the
consultation hours. The first visit to the transition clinic
takes place in the children’s hospital. If the CCS feels
ready, the following visit is located in the adult hospital
but still attended by the pediatric team. During LTFU
care, latest at the last visit before the transition, all CCSs
receive an individualized survivorship care plan (SCP).
The SCP summarizes the diagnosis, disease course and
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treatment received, including the cumulative doses of
chemotherapeutic agents, radiotherapy, surgery, and in-
formation on hematopoietic stem cell transplantation. In
addition, the SCP provides information about the indi-
vidual risk of each CCS for late effects based on the
treatment received and gives recommendations for
follow-up examinations, including the interval. The goal
of the transition clinic is to facilitate a slow and gradual
transfer from pediatric to adult medicine. We integrated
the questionnaire for this study into the transition clinic
visit and asked the CCSs to participate after their annual
LTFU consultation in the children’s hospital. After a ver-
bal explanation of the study, a medical student handed
out the study information and the informed consent
form. After receiving the signed informed consent form,
the questionnaire was filled out. The questionnaire was
anonymous, and we did not gather further information
from the CCSs’ medical records as this was a feasibility
study only. We chose a random sample of 50 CCSs dur-
ing a 9-month period.
Analysis
We used descriptive statistics to describe the study
population and summarize the answers to the CWS and
SMSS. We transformed the answers of the CWS into the
respective score ranging from 0 to 100 as mentioned in
Klassen et al. [13]. We used STATA software (Version
16.0, Stata Corporation, Austin, TX) for the analysis.
Results
Characteristics of the study population
Most of the 50 CCSs participating in this study had been
diagnosed with leukemia (46%), followed by lymphoma
and solid tumors (18% each) (Table 1). The median age
at cancer diagnosis was 10 years (interquartile range
[IQR] 4–13), with nearly half of the CCSs diagnosed be-
tween 11 and 15 years of age. Most CCSs reported being
treated with chemotherapy only (40%) followed by a
combination of chemotherapy and surgery (24%) or add-
itional radiotherapy (14%). Most CCSs remembered their
cancer diagnosis (94%), and only 8% were not able to
recall their age at diagnosis. All CCSs approached for
this study confirmed their willingness to participate and
filled out the questionnaire, and the participation rate
was 100%. The questionnaire took the CCSs approxi-
mately 10 min to complete.
Cancer worry scale (CWS)
All 50 CCSs answered all six items on the CWS and
contradicted most of the statements with “Strongly dis-
agree” or “Disagree”, which indicates a low to moderate
level of cancer-related worry (Table 2). The median
CWS score was 62 (IQR 55–71). Nevertheless, approxi-
mately 40% agreed or strongly agreed that they worry
about possible late effects (44%), that they worry about
not being able to have children in the future (40%), and
that cancer is always in the back of their mind (42%).
One-fourth of the CCSs worried about relapse (25%)
and the development of a second malignancy (24%).
Self-management skills scale (SMSS)
The answers to the SMSS indicate a relatively high level
of autonomy of the survivors, with good self-
management skills, as 63 to 100% of the CCSs’ answers
were either “Agree” or “Strongly agree” (Table 3).
Particularly in the areas of decision-making, communi-
cation, access to medical care and insurance, the partici-
pants show a high level of self-management. There were
deficits and room for improvement in five areas in which
less than 80% answered the items positively (Q5, Q9,
Q11, and Q13). Three of these items assessed the CCSs’
level of responsibility and independence: one-third (36%)
preferred to have the doctor speak to their parents in-
stead of to them (Q9), one-fourth (24%) preferred to see
a doctor or nurse together with their parents (Q11), and
one-fifth (20%) did not book their appointments them-
selves (Q13). The fourth item (Q5) shows that nearly
one-third (28%) of the participants disagreed or strongly
disagreed with the statement: “I talk to a doctor or nurse
when I have health concerns”. Furthermore, 16% denied
Table 1 Clinical characteristics of all participating childhood






CNS tumors 6 (12)
Solid tumors 9 (18)
NA 3 (6)
Age at diagnosis






Chemotherapy only 20 (40)
Chemotherapy and radiotherapy 6 (12)
Chemotherapy and surgery 12 (24)
Radiotherapy and surgery 2 (4)
Chemotherapy, radiotherapy and surgery 7 (14)
Chemotherapy, radiotherapy, surgery and
transplantation
3 (6)
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talking to other people about their medical conditions
(Q6). Five items were not answered by one or two par-
ticipants (Q7, Q9, Q11, Q12, and Q15).
Discussion
Our study shows that the CWS and SMSS can be easily
integrated into routine clinical visits. CCSs were very
willing to complete the scales, and the time needed to
complete them was short. The scales help clinicians to
assess where each CCS individually stands in the transi-
tion process, in which areas additional support is
needed, and in which areas the existing resources need
to be strengthened.
CWS in Swiss and Canadian CCSs and in the context of
the existing literature
In a Canadian cross-sectional study, including 73 CCSs,
the same scales were used [14]. Regarding type of cancer
diagnosis, only data from 56 CCSs were available in the
Canadian study. The distribution is largely comparable
with our cohort for leukemia (46% vs 47%), but differs
for lymphoma (18% vs 32%) and solid tumors. CNS
tumors were not grouped separately in the Canadian co-
hort, but represented 12% of our cohort. Swiss CCSs
showed lower levels of cancer-related worries than Can-
adian CCSs (mean CWS score in Swiss CCSs 61.9 ± 15.6;
in Canadian CCSs 50.6 ± 18.4) [14]. For the vast majority
of CCSs, cancer was not a worry that was present every
day. Nevertheless, one in five CCSs worried about re-
lapse or the development of a second tumor, and ap-
proximately 40% worried about possible late effects,
including fertility issues. The worries about secondary
tumors and late effects could potentially be increased by
physicians’ increasing efforts to educate CCSs about rea-
sons for attending and adhering to LTFU care. The explan-
ation and handing over of the individualized survivorship









1. I worry it might be difficult to have children in the future. 13 (26) 17 (34) 16 (32) 4 (8)
2. I worry about late effects that might happen to me
(Note: late effects are health problems caused by cancer
treatments, e.g. heart problems, hearing loss, learning problems).
6 (12) 22 (44) 16 (32) 6 (12)
3. Cancer is always at the back of my mind. 8 (16) 21 (42) 17 (34) 4 (8)
4. I worry about getting a new type of cancer. 13 (26) 25 (50) 10 (20) 2 (4)
5. I worry my cancer will come back (i.e. relapse). 16 (32) 21 (42) 11 (22) 2 (4)
6. I worry about my cancer every day 34 (68) 15 (30) 1 (2) 0 (0)
Score: Mean 61.9 (SD ±15.6)
Median 62 (IQR 55–71)











Q1 I answer a doctor or nurse’s questions. 0 (0) 0 (0) 17 (34) 33 (66) 0 (0)
Q2 I participate in making decisions about my health. 0 (0) 0 (0) 22 (44) 28 (56) 0 (0)
Q3 I make sure I go to all my doctor’s appointments. 0 (0) 1 (2) 12 (24) 37 (74) 0 (0)
Q4 I ask the doctor or nurse questions. 0 (0) 8 (16) 30 (60) 12 (24) 0 (0)
Q5 I talk to a doctor or nurse when I have health concerns. 2 (4) 12 (24) 23 (46) 13 (26) 0 (0)
Q6 I talk about my medical condition to people when I need to. 1 (2) 7 (14) 27 (54) 15 (30) 0 (0)
Q7 I am in charge of taking any medicine that I need. 0 (0) 3 (6) 18 (37) 28 (57) 1 (2)
Q8 I know how to contact a doctor if I need to. 0 (0) 1 (2) 21 (42) 28 (56) 0 (0)
Q9 I prefer it when a doctor speaks to me instead of my parent(s). 1 (2) 17 (34) 18 (36) 13 (26) 1 (2)
Q10 I can briefly describe my medical history when asked. 1 (2) 4 (8) 25 (50) 20 (40) 0 (0)
Q11 I prefer to see a doctor or nurse without my parent(s) with me. 1 (2) 11 (22) 19 (38) 18 (36) 1 (2)
Q12 I know how to access medical care when I travel. 0 (0) 2 (4) 29 (58) 18 (36) 1 (2)
Q13 I book my own doctor’s appointments. 1 (2) 9 (18) 20 (40) 20 (40) 0 (0)
Q14 I know the type of medical insurance I have. 0 (0) 7 (14) 25 (50) 18 (36) 0 (0)
Q15 I fill my own prescriptions when I need medicine. 1 (2) 6 (12) 20 (40) 21 (42) 2 (4)
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care plan, which also includes surveillance recommenda-
tions for potential late effects, may cause worries. This
shows that educating CCSs about possible late effects is a
balancing act between “too much” education, which might
lead to worries, and “too little” education, which probably
creates fewer or no worries but results in a lack of know-
ledge of LTFU care. Informing patients is important, as a
lack of knowledge can cause patients to become lost to
follow-up [7, 15]. This underlines that worries need to be
actively addressed. When handing over a document to the
CCSs, such as an SCP, it is important to provide the con-
tact details of someone who can be reached in case of
questions.
Results of the SMSS in the context of the existing literature
Participants showed an overall high level of self-
management, as 80% or more agreed or strongly agreed
with most of the statements (n = 11/15) on the SMSS.
Three of the four statements (Q5, Q9, Q11, Q13) that
indicated lower levels of self-management were linked to
parental involvement (Q9, Q11, Q13) and reflected a
certain dependency of the CCSs on their parents. This is
congruent with other studies, which showed that some
CCSs prefer parental involvement in the transition
process and perceive this involvement as a facilitating
factor [16, 17]. Parents of CCSs are used to taking on re-
sponsibility in the course of their child’s disease [12].
Therefore, CCSs first have to learn to manage their
health care needs alone or with the parents in a support-
ing role but not taking the lead. In addition, parents
sometimes struggle to hand over responsibility to their
child [18], and CCSs admit receiving a certain benefit
from ongoing parental support, such as making appoint-
ments, making decisions, and keeping important infor-
mation [19]. One-quarter (24%) of CCSs preferred to see
a doctor or nurse together with their parents. Compar-
ing the answers to the questions about “speaking to the
doctor” (Q9) and “seeing a doctor alone” (Q11), we saw
that they were not congruent. Only seven CCSs (16%; 7/
48) preferred to see a doctor or nurse together with their
parents and also preferred when the doctor spoke to the
parents instead of the CCS. This may indicate that some
parents accompany the children for support and play a
rather passive role during the clinical visit. This is sup-
ported by the results of the qualitative study (focus
group) of Frederick et al., which showed that despite the
participants’ desire to be perceived as an independent
person, they mentioned the parental support, especially
in administrative and organizational matters, as helpful
[19]. Nevertheless, an early and active involvement of
CCSs in their health management could help to prevent
a too strong dependence on the parents and should start
years before the transition [19–21]. In addition to promote
independence in CCSs, it is equally important to support
parents when they are transferring responsibility to their chil-
dren. This leads to a gradual change from a patient-parent-
physician triad to a patient-physician dyad. To achieve this
change in role successfully, good communication is essential
[19]. Our cohort was found to have room for improvement
regarding communication. Only 72% of participants would
talk to a doctor or nurse in case of health care concerns.
Feeling comfortable asking questions and talking about
health concerns is essential to become independent and im-
prove self-management. One out of five CCSs (20%) reported
that they did not book appointments themselves. Interest-
ingly, seven CCSs who went to the appointments alone did
not book the appointment themselves. This may indicate
that these CCSs take responsibility for and have self-
management skills regarding clinical visits, but administrative
and organizational tasks are still taken care of by the parents.
This result again goes in line with the findings of Fredericks
et al., mentioned previously [19]. Patients at our hospital re-
ceive their planned appointment times in the mail several
months in advance. Therefore, it is also possible that these
patients reported that they did not make the appointment
themselves because they received it from the hospital. The
question about whether the CSSs booked appointments
themselves (Q13) might not be valid in our population.
SMSS in Swiss and Canadian CSSs
Regarding self-management, Swiss CCSs were less likely
to address their health concerns to doctors, nurses, and
other people than were Canadian CCSs and preferred
when doctors spoke to their parents instead of them
[14]. However, the proportion of Canadian CCSs who
preferred to see the doctor or nurse together with their
parents was slightly higher than that in the Swiss cohort
(24% Swiss CCSs, 30% Canadian CCSs) [14]. Concerning
health insurance and access to medical care, Swiss CCSs
showed a relatively higher level of self-management than
Canadian CCSs, as greater proportions of Swiss CCSs
knew what type of medical insurance they have (86% vs.
63%) and how to access medical care when traveling
(96% vs. 65%) [14]. Differences in health care systems
and insurance between Switzerland and Canada might
partially explain this situation. In Switzerland, children
and adolescents up to the age of 18 years are insured
through their parents; afterwards, it is their own respon-
sibility, and they have to decide among multiple insur-
ance options and providers. Health insurance always
involves a so called “franchise” – a fixed deductible ran-
ging from CHF 300 to 2′500. The franchise is the
amount of a physician or hospital bill that must be paid
in full by the insured party before the bills are partially
paid by health insurance (max. 90% of the costs). How-
ever, the lower the franchise is, the higher the annual
health insurance contribution. In Switzerland, health in-
surance is not paid by the employer nor is it deducted
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from an individual’s salary. In addition to health insur-
ance, Switzerland has disability insurance. In cases of
many specific types of childhood cancer, this insurance
covers all costs, without a franchise, until the age of 20
years. In Canada, the universal health care system is pub-
licly funded through taxes with separate health insurance
plans for each province and territory [22, 23]. It is free for
all Canadian citizens and gives access to basic medical ser-
vices. Private insurance is needed for special services, such
as drug prescriptions, dental care, home care or long-term
care, physiotherapy, ambulance services or the prescrip-
tion of glasses. The main difference between the Swiss
and Canadian health care systems is that Swiss CCSs have
to actively deal with health insurance, either when they
are 18 years old or when they are 20 years old, and in
Canada, everyone automatically has basic insurance. This
may explain why Swiss CCSs’ knowledge of insurance was
superior to that of Canadian CCSs.
Strengths and limitations
The random sample of CCSs included in this study is
broadly representative of 5-year survivors. Compared to
the Swiss Childhood Cancer Survivor Study (SCCSS),
which also included 5-year CCSs, our cohort had more
patients with leukemia (46% vs 36%) but similar propor-
tions of children diagnosed with lymphoma (18% vs 19%)
and tumors of the CNS (12% vs 12%) [24]. We had a
response rate of 100% and a very low number of
unanswered questions. We think that social desirability
bias played a minor role, since the evaluation also revealed
critical responses and recruitment was done by a medical
student who was not part of the treatment team.
The answers to the CWS might be biased because the
CCSs completed the questionnaire directly after the visit.
During the visit, already existing late effects were ad-
dressed and their possible occurrence in the future was
mentioned. This could have activated worries that would
otherwise not be present in the CCSs’ everyday lives.
Conclusion
The translated CWS and SMSS are helpful tools in the
assessment of transition readiness in Swiss CSSs, as they
are easy to understand, quick to complete, and can be
integrated into regular LTFU care.
Nevertheless, these questionnaires are not suitable as
standalone instruments to determine a patient’s transi-
tion readiness. There would be a benefit to the longitu-
dinal completion of these tools by CCSs to assess their
advances in transition readiness and to determine the
ideal individual time point for transition. Therefore, we
will have all survivors, 15 years of age and older, fill out
the scales at annual intervals in the future and will make
it a regular component of LTFU care and the transition
to adult-focused follow-up.
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